Smith Group Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $662K | Hold |
|
|||||
|
2025
Q1 | $1.03M | Sell |
|
|||||
|
2024
Q4 | $776K | Buy |
|
|||||
|
2024
Q3 | $706K | Buy |
|
|||||
|
2024
Q2 | $396K | Buy |
|
|||||
|
2024
Q1 | $305K | Hold |
|
|||||
|
2023
Q4 | $393K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $540K | Sell |
|
|||||
|
2021
Q2 | $635K | Sell |
|
|||||
|
2021
Q1 | $693K | Sell |
|
|||||
|
2020
Q4 | $1.59M | Sell |
|
|||||
|
2020
Q3 | $1.22M | Sell |
|
|||||
|
2020
Q2 | $1.29M | Buy |
|
|||||
|
2020
Q1 | $884K | Buy |
|
|||||
|
2019
Q4 | $453K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $526K | Sell |
|
|||||
|
2018
Q2 | $1.52M | Sell |
|
|||||
|
2018
Q1 | $2.54M | Sell |
|
|||||
|
2017
Q4 | $4.6M | Sell |
|
|||||
|
2017
Q3 | $5.13M | Buy |
|
|||||
|
2017
Q2 | $3.12M | Buy |
|
|||||
|
2017
Q1 | $944K | Sell |
|
|||||
|
2016
Q4 | $626K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $164K | Buy |
|
|||||
|
2016
Q1 | $83K | Buy |
|
|||||
|
2015
Q4 | $68K | Buy |
|